LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: The authors reply.

    Plata-Menchaca, Erika P / Ferrer, Ricard

    Critical care medicine

    2021  Volume 49, Issue 6, Page(s) e660–e661

    Language English
    Publishing date 2021-05-17
    Publishing country United States
    Document type Research Support, Non-U.S. Gov't ; Letter ; Comment
    ZDB-ID 197890-1
    ISSN 1530-0293 ; 0090-3493
    ISSN (online) 1530-0293
    ISSN 0090-3493
    DOI 10.1097/CCM.0000000000004997
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Procalcitonin Is Useful for Antibiotic Deescalation in Sepsis.

    Plata-Menchaca, Erika P / Ferrer, Ricard

    Critical care medicine

    2021  Volume 49, Issue 4, Page(s) 693–696

    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Biomarkers/blood ; Health Status Indicators ; Humans ; Intensive Care Units ; Procalcitonin/blood ; Sepsis/blood ; Sepsis/drug therapy ; Time Factors
    Chemical Substances Anti-Bacterial Agents ; Biomarkers ; Procalcitonin
    Language English
    Publishing date 2021-08-30
    Publishing country United States
    Document type Editorial
    ZDB-ID 197890-1
    ISSN 1530-0293 ; 0090-3493
    ISSN (online) 1530-0293
    ISSN 0090-3493
    DOI 10.1097/CCM.0000000000004776
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Evidence for the Application of Sepsis Bundles in 2021.

    Plata-Menchaca, Erika P / Ruiz-Rodríguez, Juan Carlos / Ferrer, Ricard

    Seminars in respiratory and critical care medicine

    2021  Volume 42, Issue 5, Page(s) 706–716

    Abstract: Sepsis represents a severe condition that predisposes patients to a high risk of death if its progression is not ended. As with other time-dependent conditions, the performance of determinant interventions has led to significant survival benefits and ... ...

    Abstract Sepsis represents a severe condition that predisposes patients to a high risk of death if its progression is not ended. As with other time-dependent conditions, the performance of determinant interventions has led to significant survival benefits and quality-of-care improvements in acute emergency care. Thus, the initial interventions in sepsis are a cornerstone for prognosis in most patients. Even though the evidence supporting the hour-1 bundle is perfectible, real-life application of thoughtful and organized sepsis care has improved survival and quality of care in settings promoting compliance to evidence-based treatments. Current evidence for implementing the Surviving Sepsis Campaign bundles for early sepsis management is moving forward to better approaches as more substantial evidence evolves.
    MeSH term(s) Critical Care ; Hospital Mortality ; Humans ; Prognosis ; Sepsis/diagnosis ; Sepsis/therapy ; Shock, Septic
    Language English
    Publishing date 2021-09-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1183617-9
    ISSN 1098-9048 ; 1069-3424
    ISSN (online) 1098-9048
    ISSN 1069-3424
    DOI 10.1055/s-0041-1733899
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Risk factors and outcomes of ventilator-associated pneumonia in COVID-19 patients: a propensity score matched analysis.

    Martínez-Martínez, María / Plata-Menchaca, Erika P / Nuvials, Francesc X / Roca, Oriol / Ferrer, Ricard

    Critical care (London, England)

    2021  Volume 25, Issue 1, Page(s) 235

    MeSH term(s) Adult ; Aged ; COVID-19/complications ; COVID-19/mortality ; COVID-19/therapy ; Female ; Humans ; Male ; Middle Aged ; Pneumonia, Ventilator-Associated/etiology ; Pneumonia, Ventilator-Associated/mortality ; Propensity Score ; Respiration, Artificial/adverse effects ; Respiration, Artificial/statistics & numerical data ; Retrospective Studies ; Risk Factors ; Spain
    Language English
    Publishing date 2021-07-06
    Publishing country England
    Document type Letter
    ZDB-ID 2041406-7
    ISSN 1466-609X ; 1364-8535
    ISSN (online) 1466-609X
    ISSN 1364-8535
    DOI 10.1186/s13054-021-03654-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Evidence for the Application of Sepsis Bundles in 2021

    Plata-Menchaca, Erika P. / Ruiz-Rodríguez, Juan Carlos / Ferrer, Ricard

    Seminars in Respiratory and Critical Care Medicine

    (Sepsis and Septic Shock)

    2021  Volume 42, Issue 05, Page(s) 706–716

    Abstract: Sepsis represents a severe condition that predisposes patients to a high risk of death if its progression is not ended. As with other time-dependent conditions, the performance of determinant interventions has led to significant survival benefits and ... ...

    Series title Sepsis and Septic Shock
    Abstract Sepsis represents a severe condition that predisposes patients to a high risk of death if its progression is not ended. As with other time-dependent conditions, the performance of determinant interventions has led to significant survival benefits and quality-of-care improvements in acute emergency care. Thus, the initial interventions in sepsis are a cornerstone for prognosis in most patients. Even though the evidence supporting the hour-1 bundle is perfectible, real-life application of thoughtful and organized sepsis care has improved survival and quality of care in settings promoting compliance to evidence-based treatments. Current evidence for implementing the Surviving Sepsis Campaign bundles for early sepsis management is moving forward to better approaches as more substantial evidence evolves.
    Keywords sepsis ; surviving sepsis campaign bundles ; sepsis management ; sepsis bundles
    Language English
    Publishing date 2021-09-20
    Publisher Thieme Medical Publishers, Inc.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 1183617-9
    ISSN 1098-9048 ; 1069-3424
    ISSN (online) 1098-9048
    ISSN 1069-3424
    DOI 10.1055/s-0041-1733899
    Database Thieme publisher's database

    More links

    Kategorien

  6. Article ; Online: Blood purification in sepsis and COVID-19: what´s new in cytokine and endotoxin hemoadsorption.

    Ruiz-Rodríguez, Juan Carlos / Plata-Menchaca, Erika P / Chiscano-Camón, Luis / Ruiz-Sanmartin, Adolf / Ferrer, Ricard

    Journal of Anesthesia, Analgesia and Critical Care (Online)

    2022  Volume 2, Issue 1, Page(s) 15

    Abstract: Sepsis and COVID-19 are two clinical conditions that can lead to a dysregulated inflammatory state causing multiorgan dysfunction, hypercytokinemia, and a high risk of death. Specific subgroups of critically ill patients with particular characteristics ... ...

    Abstract Sepsis and COVID-19 are two clinical conditions that can lead to a dysregulated inflammatory state causing multiorgan dysfunction, hypercytokinemia, and a high risk of death. Specific subgroups of critically ill patients with particular characteristics could benefit from rescue treatment with hemoadsorption. There is a lack of adequately designed randomized controlled trials evaluating the potential benefits of cytokine or endotoxin hemoadsorption. Critically ill COVID-19 patients with severe acute respiratory failure poorly responsive to conventional treatment could be candidates to receive cytokine hemoadsorption in the presence of high levels of interleukin 6. This treatment can also be suitable for patients with refractory septic shock and hypercytokinemia. In the context of high endotoxin activity, hemoadsorption with polymyxin B could improve clinical parameters and the prognosis of patients with refractory septic shock. Predictive enrichment, using biomarkers or other individual features, identifies potential responders to cytokine, endotoxin, or sequential hemoadsorption. Besides, recognizing the particular subsets of patients likely to respond to one or both types of hemoadsorption will aid the design of future studies that accurately validate the effectiveness of these therapies.
    Language English
    Publishing date 2022-04-04
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2731-3786
    ISSN (online) 2731-3786
    DOI 10.1186/s44158-022-00043-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Antibiotic treatment in patients with sepsis: a narrative review.

    Plata-Menchaca, Erika P / Ferrer, Ricard / Ruiz Rodríguez, Juan Carlos / Morais, Rui / Póvoa, Pedro

    Hospital practice (1995)

    2020  Volume 50, Issue 3, Page(s) 203–213

    Abstract: Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, with unacceptably high morbidity and mortality. Similar to acute myocardial infarction or cerebral vascular accident, sepsis is a severe and ... ...

    Abstract Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, with unacceptably high morbidity and mortality. Similar to acute myocardial infarction or cerebral vascular accident, sepsis is a severe and continuous time-dependent condition. Thus, in the case of sepsis, early and adequate administration of antimicrobials must be a priority, ideally within the first hour of diagnosis, simultaneously with organ support.As a consequence of the emergence of multidrug-resistant pathogens, the choice of antimicrobials should be performed according to the local pathogen patterns of resistance. Individual antimicrobial optimization is essential to achieve adequate concentrations of antimicrobials, to reduce adverse effects, and to ensure successful outcomes, as well as preventing the emergence of multidrug-resistant pathogens. The loading dose is the administration of an initial higher dose of antimicrobials, regardless of the presence of organ dysfunction. Further doses should be implemented according to pharmacokinetics/pharmacodynamics of antimicrobials and should be adjusted according to the presence of renal or liver dysfunction. Extended or continuous infusion of beta-lactams and therapeutic drug monitoring can help to achieve therapeutic levels of antimicrobials. Duration and adequacy of treatment must be reviewed at regular intervals to allow effective de-escalation and administration of short courses of antimicrobials for most patients. Antimicrobial stewardship frameworks, leadership, focus on the optimal duration of treatments, de-escalation, and novel diagnostic stewardship approaches will help us to improve patients the process of care and overall quality of care.
    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship ; Drug Monitoring ; Humans ; Sepsis/drug therapy ; Shock, Septic
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2020-07-20
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2570453-9
    ISSN 2377-1003 ; 2154-8331 ; 8750-2836
    ISSN (online) 2377-1003
    ISSN 2154-8331 ; 8750-2836
    DOI 10.1080/21548331.2020.1791541
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: An approach to antibiotic treatment in patients with sepsis.

    Martínez, María Luisa / Plata-Menchaca, Erika P / Ruiz-Rodríguez, Juan Carlos / Ferrer, Ricard

    Journal of thoracic disease

    2019  Volume 12, Issue 3, Page(s) 1007–1021

    Abstract: Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, which is time-dependent and associated with unacceptably high mortality. Thus, when treating suspicious or confirmed cases of sepsis, ... ...

    Abstract Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, which is time-dependent and associated with unacceptably high mortality. Thus, when treating suspicious or confirmed cases of sepsis, clinicians must initiate broad-spectrum antimicrobials within the first hour of diagnosis. Optimizing antibiotic use is essential to ensure successful outcomes and to reduce adverse antibiotic effects, as well as preventing drug resistance. All likely pathogens involved should be considered to provide an appropriate antibiotic coverage. Clinicians must investigate on the previous risk of multidrug-resistant (MDR) pathogens, and the principle of individualized dosing should replace the principle of standard dosing. The loading dose is an initial higher dose of an antibiotic for all patients, yet an individualized treatment approach for further doses should be implemented according to pharmacokinetics (PK)/pharmacodynamics (PD) and the presence of renal/liver dysfunction. Extended or continuous infusion of beta-lactams and therapeutic drug monitoring (TDM) can help to achieve therapeutic levels of antimicrobials. Reevaluation of duration and appropriateness of treatment at regular intervals are also necessary. De-escalation and shortened courses of antimicrobials must be considered for most patients, except in some justified circumstances. Leadership, teamwork, antimicrobial stewardship (AS) frameworks, guideline's recommendations on the optimal duration of treatments, de-escalation, and novel diagnostic stewardship approaches will help us to improve patients' quality of care.
    Language English
    Publishing date 2019-05-13
    Publishing country China
    Document type Journal Article ; Review
    ZDB-ID 2573571-8
    ISSN 2077-6624 ; 2072-1439
    ISSN (online) 2077-6624
    ISSN 2072-1439
    DOI 10.21037/jtd.2020.01.47
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Vitamin C deficiency in critically ill COVID-19 patients admitted to intensive care unit.

    Chiscano-Camón, Luis / Ruiz-Rodriguez, Juan Carlos / Plata-Menchaca, Erika P / Martin, Laura / Bajaña, Ivan / Martin-Rodríguez, Cristina / Palmada, Clara / Ferrer-Costa, Roser / Camos, Silvia / Villena-Ortiz, Yolanda / Ribas, Vicent / Ruiz-Sanmartin, Adolf / Pérez-Carrasco, Marcos / Ferrer, Ricard

    Frontiers in medicine

    2023  Volume 10, Page(s) 1301001

    Abstract: Objectives: To determine vitamin C plasma kinetics, through the measurement of vitamin C plasma concentrations, in critically ill Coronavirus infectious disease 2019 (COVID-19) patients, identifying eventually the onset of vitamin C deficiency.: ... ...

    Abstract Objectives: To determine vitamin C plasma kinetics, through the measurement of vitamin C plasma concentrations, in critically ill Coronavirus infectious disease 2019 (COVID-19) patients, identifying eventually the onset of vitamin C deficiency.
    Design: Prospective, observational, single-center study.
    Setting: Intensive Care Unit (ICU), Vall d'Hebron University Hospital, Barcelona. Study period from November 12th, 2020, to February 24th, 2021.
    Patients: Patients who had a severe hypoxemic acute respiratory failure due to COVID-19 were included.
    Interventions: Plasma vitamin C concentrations were measured on days 1, 5, and 10 of ICU admission. There were no vitamin C enteral nor parenteral supplementation. The supportive treatment was performed following the standard of care or acute respiratory distress syndrome (ARDS) patients.
    Measurement: Plasma vitamin C concentrations were analyzed using an ultra-performance liquid chromatography (UPLC) system with a photodiode array detector (wavelength set to 245 nm). We categorized plasmatic levels of vitamin C as follows: undetectable: < 1,5 mg/L, deficiency: <2 mg/L. Low plasma concentrations: 2-5 mg/L; (normal plasma concentration: > 5 mg/L).
    Main results: Forty-three patients were included (65% men; mean age 62 ± 10 years). The median Sequential Organ Failure Assessment (SOFA) score was 3 (1-4), and the Acute Physiology and Chronic Health disease Classification System (APACHE II) score was 13 (10-22). Five patients had shock. Bacterial coinfection was documented in 7 patients (16%). Initially all patients required high-flow oxygen therapy, and 23 (53%) further needed invasive mechanical ventilation during 21 (± 10) days. The worst PaO
    Conclusion: This observational study showed vitamin C plasma levels were undetectable on ICU admission in 86% of patients with acute respiratory failure due to COVID-19 pneumonia requiring respiratory support. This finding remained consistent throughout the study period.
    Language English
    Publishing date 2023-12-20
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2023.1301001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Precision medicine in sepsis and septic shock: From omics to clinical tools.

    Ruiz-Rodriguez, Juan Carlos / Plata-Menchaca, Erika P / Chiscano-Camón, Luis / Ruiz-Sanmartin, Adolfo / Pérez-Carrasco, Marcos / Palmada, Clara / Ribas, Vicent / Martínez-Gallo, Mónica / Hernández-González, Manuel / Gonzalez-Lopez, Juan J / Larrosa, Nieves / Ferrer, Ricard

    World journal of critical care medicine

    2022  Volume 11, Issue 1, Page(s) 1–21

    Abstract: Sepsis is a heterogeneous disease with variable clinical course and several clinical phenotypes. As it is associated with an increased risk of death, patients with this condition are candidates for receipt of a very well-structured and protocolized ... ...

    Abstract Sepsis is a heterogeneous disease with variable clinical course and several clinical phenotypes. As it is associated with an increased risk of death, patients with this condition are candidates for receipt of a very well-structured and protocolized treatment. All patients should receive the fundamental pillars of sepsis management, which are infection control, initial resuscitation, and multiorgan support. However, specific subgroups of patients may benefit from a personalized approach with interventions targeted towards specific pathophysiological mechanisms. Herein, we will review the framework for identifying subpopulations of patients with sepsis, septic shock, and multiorgan dysfunction who may benefit from specific therapies. Some of these approaches are still in the early stages of research, while others are already in routine use in clinical practice, but together will help in the effective generation and safe implementation of precision medicine in sepsis.
    Language English
    Publishing date 2022-01-09
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2220-3141
    ISSN 2220-3141
    DOI 10.5492/wjccm.v11.i1.1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top